Vimarsana
Biggest News Aggregation in the World

Astrazeneca Ultomiris News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Astrazeneca Ultomiris. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Astrazeneca Ultomiris Today - Breaking & Trending Today

Rx Rundown: Merck, Novo Nordisk, Viking Therapeutics and more - Vimarsana News

Rx Rundown: Merck, Novo Nordisk, Viking Therapeutics and more

Check out this week’s medical marketing news, dealmaking and industry chatter.

GlobalData : FDA approval of subcutaneous Vyvgart tackles one of the unmet needs in myasthenia gravis indication, says GlobalData - Vimarsana News

GlobalData : FDA approval of subcutaneous Vyvgart tackles one of the unmet needs in myasthenia gravis indication, says GlobalData

23 Jun, 2023 FDA approval of subcutaneous Vyvgart tackles one of the unmet needs in myasthenia gravis indication, says GlobalData Share Print page Posted in...

BioBlast w/e 12 May 23 - Vimarsana News

BioBlast w/e 12 May 23

Korea Biomed has reported that Celltrion Healthcare has won bids to supply Vegzelma®, biosimilar to Genentech’s Avastin® (bevacizumab), in Italy and…

Apellis defends change in regulatory plans for closely watched eye drug - Vimarsana News

Apellis defends change in regulatory plans for closely watched eye drug

BioPharma

AstraZeneca, Argenx Score Phase III Wins in Autoimmune Space - Vimarsana News

AstraZeneca, Argenx Score Phase III Wins in Autoimmune Space

Two biologic therapeutic candidates have met their primary endpoints in phase III trials, including AstraZeneca’s Champion-NMOSD trial and Argenx’s Advance trial.